FindTrial
Sign In

Association Analysis of VEGF Inhibitors with Vascular Calcification: A Retrospective Study of Patients with Colorectal or Renal Cancer Treated with Bevacizumab

Association Analysis of VEGF Inhibitors with Vascular Calcification: A Retrospective Study of Patients with Colorectal or Renal Cancer Treated with Bevacizumab

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200064495
Enrollment
Unknown
Registered
2022-10-10
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular Calcification Occurs in Patients with Colorectal or Kidney Cancer

Interventions

Bevacizumab group :none

Sponsors

Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 years; 2. Meet the diagnosis of colorectal or kidney cancer, and have received chemotherapy; 3. Chest/abdominal CT examination before and after chemotherapy.

Exclusion criteria

Exclusion criteria: 1. Combined with rheumatic and immune diseases; 2. Combined with diseases requiring long-term (>6 months) hormonal therapy; 3. Complicated with other primary malignant tumors; 4. Combined with non-neoplastic chronic kidney disease (eGFR<60ml/min/1.73m^2); 5. Have a history of radiotherapy; 6. Complicated with hyperparathyroidism.

Design outcomes

Primary

MeasureTime frame
Aortic calcification score on chest/abdominal CT;—

Secondary

MeasureTime frame
Serum calcium;Total cholesterol;—

Countries

China

Contacts

Public ContactLei Juan

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

leijuan@mail.sysu.edu.cn+86 13650894373

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026